Is CA-125 an additional help to radiologic findings for differentiation borderline ovarian tumor from stage I carcinoma?

Acta Radiologica

Volumn 52, Issue 4, 2011, Pages 458-462

  Lee, Eun Joo ^a   Kim, See Hyung ^a   Kim, Young Hwan ^a   Lee, Hee Jung ^a  

^a Keimyung University   (South Korea)

Author keywords

Borderline ovarian tumors; CA 125; CT; MRI; Stage I carcinoma

Indexed keywords

CA-125; CT; MCNEMAR; NUMBER AND SIZE; OVARIAN TUMOR; RADIOLOGICAL FINDINGS; SOLID COMPONENTS; STATISTICAL CORRELATION; T-TESTS;

DISCRIMINANT ANALYSIS; MAGNETIC RESONANCE IMAGING; RADIOLOGY; RATING;

TUMORS;

CA 125 ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD; CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY TUMOR; RADIOGRAPHY;

ADULT; AGED; CA-125 ANTIGEN; CARCINOMA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; OVARIAN NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79960037529     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1258/ar.2011.100318     Document Type: Article

References (14)

1. International Federation of Gynecology and Obstetrics. Classification and staging of malignant tumours in the female pelvis. Acta Obstet Gynecol Scand 1971;50:1-7
2. Manchul LA, Simm J, Levin W, et al. Borderline epithelial ovarian tumors: a review of 81 cases with an assessment of the impact of treatment. Int J Radiat Oncol Biol Phy 1992;22:867-74
3. Wagner BJ, Buck JL, Seudman JD, et al. Ovarian epithelial neoplasm: radiologic-pathologic correlation. Radiographics 1994;14:1351-74
4. Osman N, O'Leary N, Mulcahy E, et al. Correlation of serum CA125 with stage, grade and survival of patients with epithelial ovarian cancer at a single centre. Ir Med J 2008;101:245-7
5. Rosen DG, Wang L, Atkinson JN, et al. Potential markers that complement expression of CA125 in epithelial ovarian cancer. Gynecol Oncol 2005;99:267-77 (Pubitemid 41502830)
6. de Souza NM, O'Neill R, McIndoe GA, et al. Borderline tumours of the ovary: CT and MRI features and tumour markers in differentiation from stage 1 disease. Am J Roentgenol 2005;184:999-1003 (Pubitemid 43899536)
7. Dobson M, Carrington BM, Radford JA, et al. The role of computed tomography in the management of ovarian tumours of borderline malignancy. Clin Radiol 1997;52:280-3
8. Grab D, Flock F, Stohr I, et al. Classification of asymptomatic adnexal masses by ultrasound, magnetic resonance imaging, and positron emission tomography. Gynecol Oncol 2000;77:454-9 (Pubitemid 30368567)
9. Takemori M, Nishimura R, Hasegawa K. Clinical evaluation of MRI in the diagnosis of borderline ovarian tumors. Acta Obstet Gynecol Scand 2002;81:157-61 (Pubitemid 34242373)
10. Jung SE, Lee JM, Rha SE, et al. CT and MR imaging of ovarian tumors with emphasis on differential diagnosis. Radiographics 2002;22:1305-25
11. Van Vierzen PB, Massuger LF, Ruys SH, et al. Borderline ovarian malignancy: ultrasound and fast dynamic MR findings. Eur J Radiol 1998;28:136-42 (Pubitemid 28442853)
12. Rieber A, Nussle K, Stohr I, et al. Preoperative diagnosis of ovarian tumors with MR imaging: comparison with transvaginal sonography, positron emission tomography, and histologic findings. Am J Roentgenol 2001;177:123-9 (Pubitemid 32578064)
13. Takeuchi M, Matsuzaki K, Nishitani H. Diffusion-weighted magnetic resonance imaging of ovarian tumors: differentiation of benign and malignant solid components of ovarian masses. J Comput Assist Tomogr 2010;34:173-6
14. Okamoto Y, Tanaka YO, Tsunoda H, et al. Malignant or borderline mucinous cystic neoplasms have a larger number of loculi than mucinous cystadenoma: a retrospective study with MR. J Magn Reson Imaging 2007;26:94-9 (Pubitemid 47235236)